Altundag K. Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients. Breast Cancer 2025 Jan 29. doi: 10.1007/s12282-025-01672.
PMID: 39881092